Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL)

NCT01238692

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

Jewish General Hospital Montreal, Quebec, Canada

Sacré-Cœur Hospital Montreal, Quebec, Canada

View Trial Details

Completed

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

NCT01168921

Conditions: Blood Platelet Disorders, CLL, Chronic Disease, +18 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Evaluation of Therapeutic Video Games for Pre-school Children With Acute Lymphoblastic Leukemia

NCT04199637

Conditions: Anxiety Disorders, Childhood Lymphoblastic Lymphoma, Hematologic Diseases, +11 more
Locations: National Yang-Ming University Taipei, Taiwan

View Trial Details

Completed

Prevalence, Etiology and Effects on Oral Health and Life Quality of Molar Incisor Hypomineralization

NCT05779332

Conditions: Child, Only, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
Locations: Sema Aydinoğlu Rize, Turkey (Türkiye)

View Trial Details

Completed

Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer

NCT00001582

Conditions: ATL, Autoimmune Diseases, B-cell Lymphoma, +14 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia

NCT03109093

Conditions: ALL, Recurrent, Adult, Disease Attributes, Hematologic Diseases, +15 more
Locations: University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany

Charité - Campus Benjamin Franklin Berlin, Germany

Uniklinik Dresden Dresden, Germany

Uniklinik Düsseldorf Düsseldorf, Germany

View all 22 locations

View Trial Details

Completed

German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00198978

Conditions: Adult Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: University of Frankfurt, Medical Dept. II Frankfurt, Germany

View Trial Details

Completed

Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath

NCT00199030

Conditions: Adult Acute Lymphocytic Leukemia T-cell, Disease Attributes, Hematologic Diseases, +18 more
Locations: University Hospital, Medical Dept. II Frankfurt, Germany

View Trial Details

Completed

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)

NCT00199056

Conditions: Adult Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: University Hospital, Medical Dept. II Frankfurt, Germany

View Trial Details

Completed

Trial of Bortezomib, Cytarabine, and Dexamethasone in Mantle Cell Lymphoma

NCT02840539

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions